Commentary: Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases

Front Oncol. 2024 Apr 5:14:1372745. doi: 10.3389/fonc.2024.1372745. eCollection 2024.

¹ The Second Department of Infectious Disease, The First Hospital of China Medical University, Shenyang, China.
² Medical Oncology Department of Gastrointestinal Cancer, Liaoning Cancer Hospital Institute, Cancer Hospital of Dalian University of Technology, Shenyang, China.

^# Contributed equally.

No abstract available

Keywords: adverse events (AEs) 1; hepatocellular carcinoma; lenvatinib; people living with HIV (PLWH); recurrence.

Publication types